
Models for infectious human diseases
About
Infectious disease accounts for more death and disability globally than either non-infectious disease or injury. This book contains a breadth of different quantitative approaches to understanding the patterns of infectious diseases in populations, and the design of control strategies to lessen their effect. The contributors bring a great variety of mathematical expertise (including deterministic and stochastic modelling and statistical data analysis) and involvement in a wide range of applied fields across the spectrum of biological, medical and social sciences. The aim is to increase interaction between specialities by describing research on many of the infectious diseases that affect humans, including both viral diseases like measles and AIDS and tropical parasitic infections. The papers are divided into groups dealing with problems relating to transmissible diseases, vaccination strategies, the consequences of treatment interventions, the dynamics of immunity, heterogeneity of populations, and prediction.
Discuss Models for infectious human diseases with other readers
Join or start a book club for Models for infectious human diseases on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.
Frequently asked questions
How do I join a book club for Models for infectious human diseases?
Sign up free on Readfeed, then browse public clubs or start your own club with Models for infectious human diseases as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.
Can I discuss Models for infectious human diseases with other readers online?
Yes. Readfeed book clubs let you chat live, share progress, and join discussions about Models for infectious human diseases with readers worldwide — whether your club is virtual, in-person, or hybrid.
Is Readfeed free?
Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.